Melatonin receptors in the eye: Location, second messengers and role in ocular physiology

Pharmacology and Therapeutics

Volumn 113, Issue 3, 2007, Pages 507-522

  Alarma Estrany, Pilar ^a   Pintor, Jesús ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Eye; Melatonin; Melatonin receptors

Indexed keywords

MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MELATONIN RECEPTOR; PINEAL BODY HORMONE; RECEPTOR SUBTYPE;

BINDING AFFINITY; BIOLOGICAL ACTIVITY; CHOROID; CILIARY BODY; CIRCADIAN RHYTHM; CONCENTRATION (PARAMETERS); CORNEA; EYE; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; LENS; MAMMAL; NONHUMAN; OCULAR BLOOD VESSEL; PINEAL BODY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RECEPTOR BINDING; RETINA; REVIEW; SCLERA; SIGNAL TRANSDUCTION; TARGET CELL;

ANIMALS; CIRCADIAN RHYTHM; HUMANS; LIGANDS; MELATONIN; MODELS, ANIMAL; OCULAR PHYSIOLOGY; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; SEASONS; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 33847641013     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2006.11.003     Document Type: Review

References (128)

1. Abe M., Itoh M.T., Miyata M., Ishikawa S., and Sumi Y. Detection of melatonin, its precursors and related enzyme activities in rabbit lens. Exp Eye Res 68 (1999) 255-262
2. Aimoto T., Rohde B.H., Chiou G.C., and Lauber J.K. N-acetyltransferase activity and melatonin level in the eyes of glaucomatous chickens. J Ocul Pharmacol 1 (1985) 149-160
3. Arendt J. Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. Rev Reprod 3 (1998) 13-22
4. Audinot V., Mailliet F., Lahaye-Brasseur C., Bonnaud A., Le Gall A., Amosse, et al. New selective ligands of human cloned melatonin MT1 and MT2 receptors. Naunyn Schmiedebergs Arch Pharmacol. 367 (2003) 553-561
5. Axelrod J. The pineal gland: a neurochemical transducer. Science 184 (1974) 1341-1348
6. Bardak Y., Ozerturk Y., Ozguner F., Durmus M., and Delibas N. Effect of melatonin against oxidative stress in ultraviolet-B exposed rat lens. Curr Eye Res 20 (2000) 225-230
7. Bartness T.J., and Goldman B.D. Mammalian pineal melatonin: a clock for all seasons. Experientia 45 (1989) 939-945
8. Beck-Friis J., Kjellman B.F., Aperia B., Unden F., von Rosen D., Ljunggren J.G., et al. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psychiatr Scand 71 (1985) 319-330
9. Bernard M., Guerlotte J., Greve P., Grechez-Cassiau A., Iuvone M.P., Zatz M., et al. Melatonin synthesis pathway: circadian regulation of the genes encoding the key enzymes in the chicken pineal gland and retina. Reprod Nutr Dev 39 (1999) 325-334
10. Bloomfield S.A., and Volgyi B. Function and plasticity of homologous coupling between AII amacrine cells. Vision Res 44 (2004) 3297-3306
11. Boussard M.F., Truche S., Rousseau-Rojas A., Briss S., Descamps S., Droual M., et al. New ligands at the melatonin binding site MT(3). Eur J Med Chem 41 (2006) 306-320
12. Brezinski A. Melatonin in humans. N Engl J Med 336 (1997) 186-195
13. Browning C., Beresford I., Fraser N., and Giles H. Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors. Br J Pharmacol 129 (2000) 877-886
14. q/11 proteins. Mol Endocrinol 13 (1999) 2025-2038
15. Buffa A., Rizzi E., Falconi M., Matteucci A., Baratta B., Fantazzini A., et al. Bromodeoxyuridine incorporation in corneal epithelium: an immunocytochemical study in rats. Boll Soc Ital Biol Sper 69 (1993) 767-773
16. Carrillo-Vico A., Guerrero J.M., Lardone P.J., and Reiter R.J. A review of the multiple actions of melatonin on the immune system. Endocrine 27 (2005) 189-200
17. Chanut E., Nguyen-Legros J., Versaux-Botteri C., Trouvin J.H., and Launay J.M. Determination of melatonin in rat pineal, plasma and retina by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl 709 (1998) 11-18
18. Chieffi G., Baccari G.C., Di Matteo L., d'Istria M., Minucci S., and Varriale B. Cell biology of the Harderian gland. Int Rev Cytol 168 (1996) 1-80
19. Chiou G.C., Aimoto T., and Chiou L.Y. Melatonergic involvement in diurnal changes of intraocular pressure in rabbit eyes. Ophthalmic Res 17 (1985) 373-378
20. Chiou G.C., and McLaughlin M.A. Studies on the involvement of melatonergic mechanism in intraocular pressure regulation. Ophthalmic Res 16 (1984) 302-306
21. Chiquet C., Claustrat B., Thuret G., Brun J., Cooper H.M., and Denis P. Melatonin concentrations in aqueous humor of glaucoma patients. Am J Ophthalmol 142 (2006) 325-327
22. Ciuffi M., Pisanello M., Pagliai G., Raimondi L., Franchi-Micheli S., Cantore M., et al. Antioxidant protection in cultured corneal cells and whole corneas submitted to UV-B exposure. J Photochem Photobiol B 71 (2003) 59-68
23. Djeridane Y., Vivien-Roels B., Simonneaux V., Miguez J.M., and Pevet P. Evidence for melatonin synthesis in rodent Harderian gland: a dynamic in vitro study. J Pineal Res 25 (1998) 54-64
24. Doolen S., Krause D.N., Dubocovich M.L., and Duckles S.P. Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol 345 (1998) 67-69
25. Doolen S., Krause D.N., and Duckles S.P. Estradiol modulates vascular response to melatonin in rat caudal artery. Am J Physiol 276 4 Pt 2 (1999) H1281-H1288
26. Doughty M.J. Morphometric analysis of the surface cells of rabbit corneal epithelium by scanning electron microscopy. Am J Anat 189 (1990) 316-328
27. Dubocovich M.L. Melatonin is a potent modulator of dopamine release in the retina. Nature 306 (1983) 782-784
28. Dubocovich M.L. Characterization of a retinal melatonin receptor. J Pharmacol Exp Ther 234 (1985) 395-401
29. Dubocovich M.L. Luzindole (N-0774): a novel melatonin receptor antagonist. J Pharmacol Exp Ther 246 (1988) 902-910
30. Dubocovich M.L. Melatonin receptors: are there multiple subtypes?. Trends Pharmacol Sci 16 (1995) 50-56
31. Dubocovich M.L., Cardinali D.P., Guardiola-Lemaitre B., Hagan R.M., Krause D.N., Sugden D., et al. Melatonin Receptors. The IUPHAR Compendium of Receptor Characterization and Classification (1998), IUPHAR Media, London 187-193
32. Dubocovich M.L., Masana M., and Benloucif S. Molecular pharmacology and function of melatonin receptor subtypes. In: Olcese J. (Ed). Molecular pharmacology and function of melatonin receptor subtypes. Melatonin after Four Decades (2000), Kluwer Academic/Plenum Publishers, New York 181-188
33. 1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol 355 (1997) 365-375
34. Dubocovich M.L., Yun K., Al-Ghoul W.M., Benloucif S., and Masana M.I. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J 12 (1998) 1211-1220
35. Ebisawa T., Karne S., Lerner M.R., and Reppert S.M. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci U S A 91 (1994) 6133-6137
36. Eison A.S., and Mullins U.L. Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in Syrian hamster RPMI 1846 melanoma cells. Life Sci 53 (1993) 393-398
37. Ekmekcioglu C., Thalhammer T., Humpeler S., Mehrabi M.R., Glogar H.D., Holzenbein T., et al. The melatonin receptor subtype MT2 is present in the human cardiovascular system. J Pineal Res 35 (2003) 40-44
38. Er H., Turkoz Y., Mizrak B., and Parlakpinar H. Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin. Ophthalmologica 2006 220 (2006) 17-22
39. Frampton P., Da Rin D., and Brown B. Diurnal variation of intraocular pressure and the overriding effects of sleep. Am J Optom Physiol Opt 64 (1987) 54-61
40. Fujieda H., Hamadanizadeh S.A., Wankiewicz E., Pang S.F., and Brown G.M. Expression of mt1 melatonin receptor in rat retina: evidence for multiple cell targets for melatonin. Neuroscience 93 (1999) 793-799
41. Fujieda H., Scher J., Hamadanizadeh S.A., Wankiewicz E., Pang S.F., and Brown G.M. Dopaminergic and GABAergic amacrine cells are direct targets of melatonin: immunocytochemical study of mt1 melatonin receptor in guinea pig retina. Vis Neurosci 17 (2000) 63-70
42. Garcia-Perganeda A., Pozo D., Guerrero J.M., and Calvo J.R. Signal transduction for melatonin in human lymphocytes: involvement of a pertussis toxin-sensitive G protein. J Immunol 159 (1997) 3774-3781
43. Gerdin M.J., Masana M.I., and Dubocovich M.L. Melatonin-mediated regulation of human MT(1) melatonin receptors expressed in mammalian cells. Biochem Pharmacol 67 (2004) 2023-2030
44. Gerdin M.J., Masana M.I., Ren D., Miller R.J., and Dubocovich M.L. Short-term exposure to melatonin differentially affects the functional sensitivity and trafficking of the hMT1 and hMT2 melatonin receptors. J Pharmacol Exp Ther. 304 (2003) 931-939
45. Godson C., and Reppert S.M. The Mel1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 138 (1997) 397-404
46. Gregory C.Y., Abrams T.A., and Hall M.O. Stimulation of A2 adenosine receptors inhibits the ingestion of photoreceptor outer segments by retinal pigment epithelium. Invest Ophthalmol Vis Sci 35 (1994) 819-825
47. Hoyle C.H.V., Peral A., and Pintor J. Melatonin potentiates tear secretion induced by diadenosine tetraphosphate in the rabbit. Eur J Pharmacol 552 (2006) 159-161
48. Huang H., Lee S.C., and Yang X.L. Modulation by melatonin of glutamatergic synaptic transmission in the carp retina. J Physiol 569 Pt 3 (2005) 857-871
49. James K., Skene D.J., Lucini V., Stankov B., and Arendt J. Characterisation of melatonin binding sites in the eye of the Japanese quail (Coturnix japonica). Gen Comp Endocrinol 100 (1995) 188-196
50. Jan J.E., Abroms I.F., Freeman R.D., Brown G.M., Espezel H., and Connolly M.B. Rapid cycling in severely multidisabled children: a form of bipolar affective disorder?. Pediatr Neurol 10 (1994) 34-39
51. Kato K., Hirai K., Nishiyama K., Uchikawa O., Fukatsu K., Ohkawa S., et al. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology 48 (2005) 301-310
52. Kittner Z., Olah I., and Toro I. Histology and ultrastructure of the the Harderian glands - accessory lacrimal gland - of the chicken. Acta Biol Acad Sci Hung 29 (1978) 29-41
53. Klein D.C., Coon S.L., Roseboom P.H., Weller J.L., Bernard M., Gastel J.A., et al. The melatonin rhythm-generating enzyme: molecular regulation of serotonin N-acetyltransferase in the pineal gland. Recent Prog Horm Res 52 (1997) 307-357 (discussion 357-8)
54. Kumanov P., Tomova A., Isidori A., and Nordio M. Altered melatonin secretion in hypogonadal men: clinical evidence. Int J Androl 28 (2005) 234-240
55. Lerner A.B., Case J.D., and Heinzelman R.V. Structure of melatonin. J Am Chem Soc 81 (1959) 6084-6085
56. Lewis P.D., Middleton B.A., and Gous R.M. Exogenous melatonin modifies rate of sexual maturation in domestic pullets. Poult Sci 85 (2006) 117-122
57. Lincoln G.A., Ebling F.J., and Almeida O.F. Generation of melatonin rhythms. Ciba Found Symp 117 (1985) 129-148
58. MacKenzie R.S., Melan M.A., Passey D.K., and Witt-Enderby P.A. Dual coupling of MT(1) and MT(2) melatonin receptors to cyclic AMP and phosphoinositide signal transduction cascades and their regulation following melatonin exposure. Biochem Pharmacol 63 (2002) 587-595
59. Mahtre M.C., van Jaarsveld A.S., and Reiter R.J. Melatonin in the lachrymal gland: first demonstration and experimental manipulation. Biochem Biophys Res Commun 153 (1988) 1186-1192
60. 3. FEBS Lett 578 (2004) 116-120
61. Martin M.T., Azpiroz F., and Malagelada J.R. Melatonin and the gastrointestinal tract. Therapie 53 (1998) 453-458
62. Martin X.D., Malina H.Z., Brennan M.C., Hendrickson P.H., and Lichter P.R. The ciliary body-the third organ found to synthesize indoleamines in humans. Eur J Ophthalmol 2 (1992) 67-72
63. Meyer P., Pache M., Loeffler K.U., Brydon L., Jockers R., Flammer J., et al. Melatonin MT-1 receptor immunoreactivity in the human eye. Br J Ophthalmol 86 (2002) 1053-1057
64. Miyamoto M. Effect of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, on motor performance in mice. Neurosci Lett 402 (2006) 201-204
65. 2 binding sites. Eur J Pharmacol 301 (1996) 159-168
66. Moller M., and Baeres F.M. The anatomy and innervation of the mammalian pineal gland. Cell Tissue Res 309 (2002) 139-150
67. Mor M., Plazzi P.V., Spadoni G., and Tarzia G. Melatonin. Curr Med Chem 6 (1999) 501-518
68. Morgan P.J., Lawson W., Davidson G., and Howell H.E. Guanine nucleotides regulate the affinity of melatonin receptors on the ovine pars tuberalis. Neuroendocrinology 50 (1989) 359-362
69. Mullins U.L., Fernandes P.B., and Eison A.S. Melatonin agonists induce phosphoinositide hydrolysis in Xenopus laevis melanophores. Cell Signal 9 (1997) 169-173
70. Natesan A.K., and Cassone V.M. Melatonin receptor mRNA localization and rhythmicity in the retina of the domestic chick Gallus domesticus. Vis Neurosci 19 (2002) 265-274
71. Navajas C., Kokkola T., Poso A., Honka N., Gynther J., and Laitinen J.T. A rhodopsin-based model for melatonin recognition at its G protein-coupled receptor. Eur J Pharmacol 304 (1996) 173-183
72. New D.C., Tsim S.T., and Wong Y.H. G protein-linked effector and second messenger systems involved in melatonin signal transduction. Neurosignals 12 (2003) 59-70
73. Nickla D.L., Rada J.A., and Wallman J. Isolated chick sclera shows a circadian rhythm in proteoglycan synthesis perhaps associated with the rhythm in ocular elongation. J Comp Physiol [A] 185 (1999) 81-90
74. Nickla D.L., Wildsoet C., and Wallman J. Visual influences on diurnal rhythms in ocular length and choroidal thickness in chick eyes. Exp Eye Res 66 (1998) 163-181
75. 3 as the quinone reductase 2. J Biol Chem 275 (2000) 31311-31317
76. 3/QR2. Biochem Pharmacol 61 (2001) 1369-1379
77. Osborne N.N. Serotonin and melatonin in the iris/ciliary processes and their involvement in intraocular pressure. Acta Neurobiol Exp (Wars) 54 (1994) 57-64 (Suppl)
78. Osborne N.N., and Chidlow G. The presence of functional melatonin receptors in the iris-ciliary processes of the rabbit eye. Exp Eye Res 59 (1994) 3-9
79. Oxenkrug G., Requintina P., and Bachurin S. Antioxidant and antiaging activity of N-acetylserotonin and melatonin in the in vivo models. Ann N Y Acad Sci 939 (2001) 190-199
80. Pache M., Krauchi K., Haefliger I.O., Wirz-Justice A., Flammer J., and Meyer P. Effect of melatonin on vascular responses of porcine ciliary arteries. Curr Eye Res 24 (2002) 313-317
81. Papastergiou G.I., Schmid G.F., Riva C.E., Mendel M.J., Stone R.A., and Laties A.M. Ocular axial length and choroidal thickness in newly hatched chicks and one-year-old chickens fluctuate in a diurnal pattern that is influenced by visual experience and intraocular pressure changes. Exp Eye Res 66 (1998) 195-205
82. 125I]iodomelatonin binding sites in Syrian hamster peripheral organs. J Pharmacol Exp Ther 290 (1999) 334-340
83. Petit L., Lacroix I., de Coppet P., Strosberg D., and Jockers R. Different signalling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3′-5′-monophosphate pathway. Biochem Pharmacol 58 (1999) 633-639
84. Pierce M.E., and Besharse J.C. Circadian regulation of retinomotor movements: I. Interaction of melatonin and dopamine in the control of cone length. J Gen Physiol 86 (1985) 671-689
85. Pintor J.J., Carracedo G., Mediero A., Guzman-Aranguez A., Irazu M., Pelaez T., et al. Melatonin increases the rate of corneal re-epithelialisation in New Zealand white rabbits. Invest Ophthalmol Vis Sci 46 (2005) A2152
86. Pintor J., Martin L., Pelaez T., Hoyle C.H., and Peral A. Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits. Eur J Pharmacol 416 (2001) 251-254
87. 3 receptor. Br J Pharmacol 138 (2003) 831-836
88. Rada J.A., and Wiechmann A.F. Melatonin receptors in chick ocular tissues: implications for a role of melatonin in ocular growth regulation. Invest Ophthalmol Vis Sci 47 (2006) 25-33
89. Reiter R.J., Tan D.X., Mayo J.C., Sainz R.M., Leon J., and Czarnocki Z. Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol 50 (2003) 1129-1146
90. Reppert S.M. Melatonin receptors: molecular biology of a new family of G protein-coupled receptors. J Biol Rhythms 12 (1997) 528-531
91. Reppert S.M., Godson C., Mahle C.D., Weaver D.R., Slaugenhaupt S.A., and Gusella J.F. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci U S A 92 (1995) 8734-8738
92. Reppert S.M., Weaver D.R., Cassone V.M., Godson C., and Kolakowski Jr. L.F. Melatonin receptors are for the birds: molecular analysis of two receptor subtypes differentially expressed in chick brain. Neuron 15 (1995) 1003-1015
93. Reppert S.M., Weaver D.R., and Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13 (1994) 1177-1185
94. Reppert S.M., Weaver D.R., and Godson C. Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol Sci 17 (1996) 100-102
95. Rivara S., Lorenzi S., Mor M., Plazzi P.V., Spadoni G., Bedini A., et al. Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models. J Med Chem 48 (2005) 4049-4060
96. Roberts J.E., Wiechmann A.F., and Hu D.N. Melatonin receptors in human uveal melanocytes and melanoma cells. J Pineal Res 28 (2000) 165-171
97. Roca A.L., Godson C., Weaver D.R., and Reppert S.M. Structure, characterization, and expression of the gene encoding the mouse Mel1a melatonin receptor. Endocrinology 137 (1996) 3469-3477 (Erratum in: Endocrinology 1997;138 2307)
98. Rohde B.H., McLaughlin M.A., and Chiou L.Y. Existence and role of endogenous ocular melatonin. J Ocul Pharmacol 1 (1985, Fall) 235-243
99. Samples J.R., Krause G., and Lewy A.J. Effect of melatonin on intraocular pressure. Curr Eye Res 7 (1988) 649-653
100. Savaskan E., Wirz-Justice A., Olivieri G., Pache M., Krauchi K., Brydon L., et al. Distribution of melatonin MT1 receptor immunoreactivity in human retina. J Histochem Cytochem 50 (2002) 519-526
101. Scher J., Wankiewicz E., Brown G.M., and Fujieda H. MT(1) melatonin receptor in the human retina: expression and localization. Invest Ophthalmol Vis Sci 43 (2002) 889-897
102. Scher J., Wankiewicz E., Brown G.M., and Fujieda H. AII amacrine cells express the MT1 melatonin receptor in human and macaque retina. Exp Eye Res 77 (2003) 375-382
103. Schomerus C., and Korf H.W. Mechanisms regulating melatonin synthesis in the mammalian pineal organ. Ann N Y Acad Sci 1057 (2005) 372-383
104. 3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes. J Glaucoma 13 (2004) 385-388
105. Sewerynek E. Melatonin and the cardiovascular system. Neuro Endocrinol Lett 23 Suppl 1 (2002) 79-83
106. Slaugenhaupt S.A., Roca A.L., Liebert C.B., Altherr M.R., Gusella J.F., and Reppert S.M. Mapping of the gene for the Mel1a-melatonin receptor to human chromosome 4(MTNR1A) and mouse chromosome 8 (Mtnr1a). Genomics 27 (1995) 355-357
107. Tosini G. Melatonin circadian rhythm in the retina of mammals. Chronobiol Int 17 (2000) 599-612
108. Tosini G., and Fukuhara C. The mammalian retina as a clock. Cell Tissue Res 309 1 (2002) 119-126
109. Tosini G., and Fukuhara C. Photic and circadian regulation of retinal melatonin in mammals. J Neuroendocrinol 15 (2003) 364-369
110. Vanecek J. Cellular mechanisms of melatonin action. Physiol Rev 78 (1998) 687-721
111. Vaughan G.M., and Reiter R.J. Pineal dependence of the Syrian hamster's nocturnal serum melatonin surge. J Pineal Res 3 (1986) 9-14
112. Vella F., Ferry G., Delagrange P., and Boutin J.A. NRH:quinone reductase 2: an enzyme of surprises and mysteries. Biochem Pharmacol 71 (2005) 1-12
113. Vollrath L. The Pineal Organ. In: Vollrath L. (Ed) (1981), Springer-Verlag, Berlín 665
114. Von Gall C., Stehle J.H., and Weaver D.R. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res 309 (2002) 151-162
115. Wahl C.M., Li T., and Howland H.C. Effects of light and melatonin on chick corneas grown in culture. ARVO E-Abstract 4293. Invest Opthalmol Vis Sci 45 (2004)
116. Wess J. Molecular basis of muscarinic acetylcholine receptor function. Trends Pharmacol Sci 14 (1993) 308-313
117. Wetterberg L. Melatonin and affective disorders. Ciba Found Symp 117 (1985) 253-265
118. White M.P., and Fisher L.J. Effects of exogenous melatonin on circadian disc shedding in the albino rat retina. Vision Res 29 (1989) 167-179
119. Wiechmann A.F., and Rada J.A. Melatonin receptor expression in the cornea and sclera. Exp Eye Res 77 (2003) 219-225
120. Wiechmann A.F., and Smith A.R. Melatonin receptor RNA is expressed in photoreceptors and displays a diurnal rhythm in Xenopus retina. Brain Res Mol Brain Res 91 (2001) 104-111
121. Wiechmann A.F., and Wirsig-Wiechmann C.R. Melatonin receptor mRNA and protein expression in Xenopus laevis nonpigmented ciliary epithelial cells. Exp Eye Res 73 (2001) 617-623
122. Wiechmann A.F., Vrieze M.J., Dighe R., and Hu Y. Direct modulation of rod photoreceptor responsiveness through a Mel(1c) melatonin receptor in transgenic Xenopus laevis retina. Invest Ophthalmol Vis Sci 44 (2003) 4522-4531
123. Wiechmann A.F., Udin S.B., and Rada J.A. Localization of Mel1b melatonin receptor-like immunoreactivity in ocular tissues of Xenopus laevis. Exp Eye Res 79 (2004) 585-594
124. Wiechmann A.F., Yang X.L., Wu S.M., and Hollyfield J.G. Melatonin enhances horizontal cell sensitivity in salamander retina. Brain Res 453 (1988) 377-380
125. Witt-Enderby P.A., Bennett J., Jarzynka M.J., Firestine S., and Melan M.A. Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci 72 (2003) 2183-2198
126. Yi C., Pan X., Yan H., Guo M., and Pierpaoli W. Effects of melatonin in age-related macular degeneration. Ann N Y Acad Sci 1057 (2005) 384-392
127. Zawilska J.B., Lorenc A., Berezinska M., Vivien-Roels B., Pevet P., and Skene D.J. Diurnal and circadian rhythms in melatonin synthesis in the turkey pineal gland and retina. Gen Comp Endocrinol 145 (2006) 162-168
128. Zlotos D.P. Recent advances in melatonin receptor ligands. Arch Pharm (Weinheim) 338 (2005) 229-247